Tom J. de Koning

7.5k total citations
153 papers, 4.6k citations indexed

About

Tom J. de Koning is a scholar working on Clinical Biochemistry, Molecular Biology and Biochemistry. According to data from OpenAlex, Tom J. de Koning has authored 153 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Clinical Biochemistry, 53 papers in Molecular Biology and 35 papers in Biochemistry. Recurrent topics in Tom J. de Koning's work include Metabolism and Genetic Disorders (60 papers), Amino Acid Enzymes and Metabolism (33 papers) and Neurological disorders and treatments (26 papers). Tom J. de Koning is often cited by papers focused on Metabolism and Genetic Disorders (60 papers), Amino Acid Enzymes and Metabolism (33 papers) and Neurological disorders and treatments (26 papers). Tom J. de Koning collaborates with scholars based in Netherlands, Sweden and United States. Tom J. de Koning's co-authors include Ruud Berger, Leo W. J. Klomp, Bwee Tien Poll‐The, L. Dorland, Marina A.J. Tijssen, Sabine A. Fuchs, Nanda M. Verhoeven‐Duif, Mieke Aldenhoven, Jaap Jan Boelens and Peter M. van Hasselt and has published in prestigious journals such as Journal of Biological Chemistry, Nature Genetics and SHILAP Revista de lepidopterología.

In The Last Decade

Tom J. de Koning

151 papers receiving 4.5k citations

Peers

Countries citing papers authored by Tom J. de Koning

Since Specialization

Citations

This map shows the geographic impact of Tom J. de Koning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom J. de Koning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom J. de Koning more than expected).

Fields of papers citing papers by Tom J. de Koning

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tom J. de Koning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom J. de Koning. The network helps show where Tom J. de Koning may publish in the future.

Co-authorship network of co-authors of Tom J. de Koning

This figure shows the co-authorship network connecting the top 25 collaborators of Tom J. de Koning. A scholar is included among the top collaborators of Tom J. de Koning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tom J. de Koning. Tom J. de Koning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The natural history of progressive myoclonus ataxia 2024 ·Neurobiology of Disease ·Sterre van der Veen, Hendriekje Eggink, Jan Willem J. Elting, Deborah A. Sival, Corien C. Verschuuren‐Bemelmans, Tom J. de Koning, Marina A.J. Tijssen	1
2	Physician’s conceptions of the decision-making process when managing febrile infants ≤ 60 days old: a phenomenographic qualitative study 2024 ·BMC Pediatrics ·Ioannis Orfanos, (unknown), (unknown), Kristina Elfving, Tobias Alfvén, Tom J. de Koning, Charlotte Castor	1
3	A Screening Tool to Quickly Identify Movement Disorders in Patients with Inborn Errors of Metabolism 2023 ·Movement Disorders ·(unknown), (unknown), Deborah A. Sival, Bettina Balint, Kailash P. Bhatia, Maria Fiorella Contarino, Martje E. van Egmond, Roberto Erro, Jennifer Friedman, Victor S.C. Fung, Christos Ganos, Manju A. Kurian, Anthony E. Lang, Eavan McGovern, Emmanuel Roze, Tom J. de Koning, Marina A.J. Tijssen	3
4	Early onset ataxia with comorbid myoclonus and epilepsy: A disease spectrum with shared molecular pathways and cortico-thalamo-cerebellar network involvement 2023 ·European Journal of Paediatric Neurology ·(unknown), Sterre van der Veen, Tom J. de Koning, (unknown), Dineke S. Verbeek, Deborah A. Sival	2
5	Gut Microbiome Composition in Dystonia Patients 2023 ·International Journal of Molecular Sciences ·(unknown), J. Casper Swarte, Ranko Gaćeša, Johannes R. Björk, Rinse K. Weersma, Marina A.J. Tijssen, Tom J. de Koning, Hermie J. M. Harmsen, Klary E. Niezen‐Koning	0
6	Eye movement disorders in inborn errors of metabolism: A quantitative analysis of 37 patients 2022 ·Journal of Inherited Metabolic Disease ·(unknown), (unknown), Hans Blokzijl, Marc Engelen, Femke C. C. Klouwer, Fiete Lange, Wilhelmina G. Leen, Roelineke J. Lunsing, Johannes H.T.M. Koelman, Aad Verrips, Tom J. de Koning, Marina A.J. Tijssen	4
7	Parkinsonism in Genetic Neurodevelopmental Disorders: A Systematic Review 2022 ·Movement Disorders Clinical Practice ·(unknown), Agnies M. van Eeghen, Tom J. de Koning, Mark L. Kuijf, Janneke Zinkstok, (unknown), Thérèse van Amelsvoort, Erik Boot	6
8	The Mitochondrial Epigenome: An Unexplored Avenue to Explain Unexplained Myopathies? 2022 ·International Journal of Molecular Sciences ·(unknown), (unknown), (unknown), (unknown), (unknown), Ingrid H. Hof, Pytrick Jellema, Tom J. de Koning, Klaas Nico Faber, Marcel H.J. Ruiters, Klary E. Niezen‐Koning, Marianne G. Rots	12
9	Serotonergic system in vivo with [11C]DASB PET scans in GTP-cyclohydrolase deficient dopa-responsive dystonia patients 2022 ·Scientific Reports ·(unknown), Débora Elisa Peretti, (unknown), Bauke M. de Jong, Rudi Dierckx, Anouk Kuiper, Tom J. de Koning, David Vállez García, Marina A.J. Tijssen	4
10	Challenges in Clinicogenetic Correlations: One Phenotype – Many Genes 2021 ·Movement Disorders Clinical Practice ·(unknown), Sterre van der Veen, Martje E. van Egmond, Tom J. de Koning, Marina A.J. Tijssen	11
11	Nomenclature of Genetically Determined Myoclonus Syndromes: Recommendations of the International Parkinson and Movement Disorder Society Task Force 2019 ·Movement Disorders ·Sterre van der Veen, Rodi Zutt, Christine Klein, Connie Marras, Samuel F. Berkovic, John N. Caviness, Hiroshi Shibasaki, Tom J. de Koning, Marina A.J. Tijssen	18
12	Variable Interpretation of the Dystonia Consensus Classification Items Compromises Its Solidity 2019 ·Movement Disorders ·Martje E. van Egmond, Maria Fiorella Contarino, (unknown), Kathryn J. Peall, Oebele F. Brouwer, Victor S.C. Fung, Emmanuel Roze, Roy E. Stewart, Michèl A.A.P. Willemsen, Nicole I. Wolf, Tom J. de Koning, Marina A.J. Tijssen	10
13	Myoclonus in childhood-onset neurogenetic disorders: The importance of early identification and treatment 2015 ·European Journal of Paediatric Neurology ·Martje E. van Egmond, Jan Willem J. Elting, Anouk Kuiper, Rodi Zutt, Kirsten R. Heineman, Oebele F. Brouwer, Deborah A. Sival, Michèl A.A.P. Willemsen, Marina A.J. Tijssen, Tom J. de Koning	21
14	D-Serine Influences Synaptogenesis in a P19 Cell Model 2012 ·JIMD Reports ·Sabine A. Fuchs, (unknown), Leo W. J. Klomp, Ruud Berger, Tom J. de Koning	3
15	Novel mutations in 3-phosphoglycerate dehydrogenase (PHGDH) are distributed throughout the protein and result in altered enzyme kinetics 2009 ·Human Mutation ·(unknown), Tom J. de Koning, (unknown), Inge E.T. van den Berg, Ruud Berger, Leo W. J. Klomp	37
16	Cerebrospinal fluid d-serine and glycine concentrations are unaltered and unaffected by olanzapine therapy in male schizophrenic patients 2008 ·European Neuropsychopharmacology ·Sabine A. Fuchs, Martina M.J. de Barse, Floor Scheepers, Wiepke Cahn, L. Dorland, Monique G. de Sain-van der Velden, Leo W. J. Klomp, Ruud Berger, René S. Kahn, Tom J. de Koning	27
17	Hypomyelination and Reversible White Matter Attenuation in 3-Phosphoglycerate Dehydrogenase Deficiency 2000 ·Neuropediatrics ·Tom J. de Koning, J. Jaeken, M. Pineda, Lionel Van Maldergem, Bwee Tien Poll‐The, Marjo S. van der Knaap	54
18	Molecular Characterization of 3-Phosphoglycerate Dehydrogenase Deficiency—a Neurometabolic Disorder Associated with Reduced L-Serine Biosynthesis 2000 ·The American Journal of Human Genetics ·Leo W. J. Klomp, Tom J. de Koning, Helga E.M. Malingré, (unknown), (unknown), Frans L. Opdam, Marinus Duran, Jaak Jaeken, Mercè Pineda, Lionel Van Maldergem, Bwee Tien Poll‐The, Inge E.T. van den Berg, Ruud Berger	86
19	Beneficial effects of L‐serine and glycine in the management of seizures in 3‐phosphoglycerate dehydrogenase deficiency 1998 ·Annals of Neurology ·Tom J. de Koning, Marinus Durán, L. Dorland, R. H. J. M. Gooskens, Emile Van Schaftingen, (unknown), Nenad Blau, Ruud Berger, Bwee Tien Poll‐The	65
20	A Novel Disorder of N-Glycosylation Due to Phosphomannose Isomerase Deficiency 1998 ·Biochemical and Biophysical Research Communications ·Tom J. de Koning, L. Dorland, O. P. van Diggelen, (unknown), (unknown), W.L. van Noort, (unknown), (unknown), Inge E.T. van den Berg, Gerrit J. Gerwig, R. Berger, Bwee Tien Poll‐The	92

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact